UNSPSC 51191804: Potassium acetate

This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M911911U02. European Medicines Agency schedules Potassium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14962MIG. Potassium acetate generally arises in the molecular formula C2H4O2.K. The term POTASSIUM ACETATE is a United States Homeopathic Pharmacopoeia Name designation. Most nations schedule potassium acetate under HS 29152900 and SITC 51371.

As of Q4 2014, POTASSIUM ACETATE remains the US FDA Preferred Term for this commodity. Potassium acetate bears US NLM identifiers UMLS ID C0137984 and NCI Concept Code C47677. SMILES: CC(=O)[O-].[K+].

UNSPSC 51191804 Potassium acetate is a Commodity code that represents chemical supply for municipal and state infrastructure operations, though the recent opportunities posted under this code show substantial category mismatch. The City of Meriden's bid for sodium bisulfite (a water treatment chemical) and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products both fall under the same code designation despite representing distinct chemical and pharmaceutical procurement streams. State and local governments use this code tier to source specialty chemicals and related products for water treatment, facility operations, and healthcare supply chains. Issuing bodies include municipal utilities, state cooperative purchasing alliances, and healthcare facilities within participating jurisdictions.

The code shows activity across Connecticut and Minnesota, with the Minnesota MMCAP serving as a multi-state cooperative purchasing vehicle extending coverage to Oregon and other participating members. The City of Meriden posted an IFB (B02715) for sodium bisulfite with a July 29, 2026 response date, requiring $1 million to $2 million in general liability coverage and performance/payment bonds. The Minnesota Department of Administration's MMCAP issued an RFP (S1070000015802) on January 20, 2026 with a March 26, 2026 due date for generic pharmaceuticals and OTC products, requiring cGMP and DSCSA compliance and establishing a two-year contract term effective July 1, 2026 with a 3 percent administrative fee. The mismatch between the code's nominal scope and the diverse commodity types posted suggests either inconsistent code assignment or that UNSPSC 51191804 functions as a catch-all for specialized chemical and pharmaceutical procurement that does not fit more granular commodity classifications.